| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1037121537 |
| P356 | DOI | 10.1186/1471-2202-11-53 |
| P932 | PMC publication ID | 2881102 |
| P698 | PubMed publication ID | 20420693 |
| P5875 | ResearchGate publication ID | 43344962 |
| P50 | author | John Christodoulou | Q42753915 |
| Assam El-osta | Q43160132 | ||
| Barry Slobedman | Q55222663 | ||
| Dimitri Minchenko | Q84113387 | ||
| P2093 | author name string | Harikrishnan K N | |
| Joanne H Gibson | |||
| Sarah L Williamson | |||
| Joshua L Stern | |||
| P2860 | cites work | Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 | Q22337290 |
| Clusterin inhibits apoptosis by interacting with activated Bax | Q24316499 | ||
| Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene are associated with severe neurodevelopmental retardation | Q24534159 | ||
| Dynamin-dependent endocytosis of ionotropic glutamate receptors | Q24642585 | ||
| FOXG1 is responsible for the congenital variant of Rett syndrome | Q24647431 | ||
| MeCP2, a key contributor to neurological disease, activates and represses transcription | Q24647533 | ||
| Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome | Q24685599 | ||
| Gene expression patterns vary in clonal cell cultures from Rett syndrome females with eight different MECP2 mutations | Q24799191 | ||
| Minimum information about a microarray experiment (MIAME)-toward standards for microarray data | Q27860569 | ||
| Differential expression of CRMP1, CRMP2A, CRMP2B, and CRMP5 in axons or dendrites of distinct neurons in the mouse brain | Q28508353 | ||
| Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome | Q28587104 | ||
| Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome | Q28592236 | ||
| Gene expression analysis exposes mitochondrial abnormalities in a mouse model of Rett syndrome | Q28592510 | ||
| Mecp2 deficiency is associated with learning and cognitive deficits and altered gene activity in the hippocampal region of mice | Q28595061 | ||
| Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation | Q29616327 | ||
| Reversal of neurological defects in a mouse model of Rett syndrome | Q29616452 | ||
| Analysis of gene expression in single live neurons | Q33209493 | ||
| Expression profiling of clonal lymphocyte cell cultures from Rett syndrome patients | Q33251357 | ||
| Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation. | Q33910551 | ||
| Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2. | Q34098728 | ||
| Selective dendritic alterations in the cortex of Rett syndrome | Q34319981 | ||
| Temporal and regional differences in the olfactory proteome as a consequence of MeCP2 deficiency | Q34337708 | ||
| Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain | Q34387585 | ||
| Up-regulation of glucocorticoid-regulated genes in a mouse model of Rett syndrome | Q34432080 | ||
| CDKL5/STK9 is mutated in Rett syndrome variant with infantile spasms | Q35447640 | ||
| Mitochondriopathies | Q35685889 | ||
| Rett syndrome: new clinical and molecular insights. | Q36545755 | ||
| Amplified RNA synthesized from limited quantities of heterogeneous cDNA. | Q37705357 | ||
| Gene expression profiling in postmortem Rett Syndrome brain: differential gene expression and patient classification. | Q38295937 | ||
| Induction of clusterin/apoJ expression by histone deacetylase inhibitors in neural cells | Q40374631 | ||
| Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines | Q41244266 | ||
| Oxidative stress in Rett syndrome | Q43819381 | ||
| Neuropathology of Rett syndrome: case report with neuronal and mitochondrial abnormalities in the brain | Q46844441 | ||
| Dynamin undergoes a GTP-dependent conformational change causing vesiculation | Q47945531 | ||
| Automated analysis of mitochondrial enzymes in cultured skin fibroblasts | Q48000393 | ||
| ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo | Q48087583 | ||
| Rett syndrome: 3-D confocal microscopy of cortical pyramidal dendrites and afferents. | Q48087777 | ||
| Altered development of glutamate and GABA receptors in the basal ganglia of girls with Rett syndrome | Q48210067 | ||
| Mice deficient in collapsin response mediator protein-1 exhibit impaired long-term potentiation and impaired spatial learning and memory. | Q48250850 | ||
| Workshop on Autonomic Function in Rett Syndrome. Swedish Rett Center Frösön, Sweden, May 1998. | Q48381651 | ||
| Methyl-CpG-binding protein 2 is localized in the postsynaptic compartment: an immunochemical study of subcellular fractions. | Q48405918 | ||
| Distribution of clusterin in Alzheimer brain tissue | Q48481992 | ||
| Sustained astrocytic clusterin expression improves remodeling after brain ischemia. | Q48652765 | ||
| Infantile hypotonia as a presentation of Rett syndrome | Q50309363 | ||
| The impact of MECP2 mutations in the expression patterns of Rett syndrome patients. | Q51935592 | ||
| Clusterin expression in follicular dendritic cells associated with prion protein accumulation | Q59691474 | ||
| Microscopic Observations of the Brain in Rett Syndrome | Q60532346 | ||
| Rett syndrome and mitochondrial enzyme deficiencies | Q68239232 | ||
| Rett syndrome: findings suggesting axonopathy and mitochondrial abnormalities | Q68605882 | ||
| Mitochondrial alterations in Rett syndrome | Q69772944 | ||
| Clusterin accumulates in dying neurons following status epilepticus | Q71589623 | ||
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | Rett syndrome | Q917357 |
| P304 | page(s) | 53 | |
| P577 | publication date | 2010-04-26 | |
| P1433 | published in | BMC Neuroscience | Q15766477 |
| P1476 | title | Downstream targets of methyl CpG binding protein 2 and their abnormal expression in the frontal cortex of the human Rett syndrome brain | |
| P478 | volume | 11 |
| Q38238636 | Aberrant redox homoeostasis and mitochondrial dysfunction in Rett syndrome |
| Q37620699 | Alterations in the carnitine cycle in a mouse model of Rett syndrome. |
| Q44824580 | Altered microtubule dynamics in Mecp2-deficient astrocytes |
| Q37607012 | Autism, Mitochondria and Polybrominated Diphenyl Ether Exposure. |
| Q42694581 | Autistic Siblings with Novel Mutations in Two Different Genes: Insight for Genetic Workups of Autistic Siblings and Connection to Mitochondrial Dysfunction |
| Q64087689 | Clusterin in Alzheimer's Disease: Mechanisms, Genetics, and Lessons From Other Pathologies |
| Q36980707 | Comparative DNA methylation among females with neurodevelopmental disorders and seizures identifies TAC1 as a MeCP2 target gene |
| Q39127494 | Constitutional Epi/Genetic Conditions: Genetic, Epigenetic, and Environmental Factors |
| Q36565518 | Correcting deregulated Fxyd1 expression ameliorates a behavioral impairment in a mouse model of Rett syndrome |
| Q37157706 | Does microglial dysfunction play a role in autism and Rett syndrome? |
| Q42111097 | Dysregulation of glutamine transporter SNAT1 in Rett syndrome microglia: a mechanism for mitochondrial dysfunction and neurotoxicity |
| Q35150197 | Elevated 5-hydroxymethylcytosine in the Engrailed-2 (EN-2) promoter is associated with increased gene expression and decreased MeCP2 binding in autism cerebellum |
| Q97542587 | Expansion of the phenotypic spectrum of de novo missense variants in kinesin family member 1A (KIF1A) |
| Q38645047 | Folate metabolism abnormalities in autism: potential biomarkers |
| Q30410996 | Gastrointestinal dysfunction in autism spectrum disorder: the role of the mitochondria and the enteric microbiome |
| Q37422466 | Genes related to mitochondrial functions, protein degradation, and chromatin folding are differentially expressed in lymphomonocytes of Rett syndrome patients |
| Q26744037 | Identification and Treatment of Pathophysiological Comorbidities of Autism Spectrum Disorder to Achieve Optimal Outcomes |
| Q47166732 | Increased Mitochondrial Mass and Cytosolic Redox Imbalance in Hippocampal Astrocytes of a Mouse Model of Rett Syndrome: Subcellular Changes Revealed by Ratiometric Imaging of JC-1 and roGFP1 Fluorescence |
| Q101451553 | Intensified mitochondrial hydrogen peroxide release occurs in all brain regions, affects male as well as female Rett mice, and constitutes a life-long burden |
| Q35838075 | Linking epigenetics to human disease and Rett syndrome: the emerging novel and challenging concepts in MeCP2 research |
| Q49724123 | MeCP2 Deficiency Leads to Loss of Glial Kir4.1. |
| Q44784279 | MeCP2 deficiency is associated with impaired microtubule stability |
| Q36578835 | MeCP2 modulates gene expression pathways in astrocytes |
| Q34193020 | MeCP2 mutation results in compartment-specific reductions in dendritic branching and spine density in layer 5 motor cortical neurons of YFP-H mice |
| Q33740585 | MeCP2 reinforces STAT3 signaling and the generation of effector CD4+ T cells by promoting miR-124-mediated suppression of SOCS5. |
| Q38273909 | Metabolic and mitochondrial disorders associated with epilepsy in children with autism spectrum disorder |
| Q38689523 | Mining for mitochondrial mechanisms: linking known syndromes to mitochondrial function |
| Q64248477 | Mitochondrial Dysfunction Is Inducible in Lymphoblastoid Cell Lines From Children With Autism and May Involve the TORC1 Pathway |
| Q37697385 | Mitochondrial Dysfunction in the Pathogenesis of Rett Syndrome: Implications for Mitochondria-Targeted Therapies |
| Q90294803 | Mitochondrial Electron Transport Chain Complex Dysfunction in MeCP2 Knock-Down Astrocytes: Protective Effects of Quercetin Hydrate |
| Q42132669 | Modulation of RhoGTPases improves the behavioral phenotype and reverses astrocytic deficits in a mouse model of Rett syndrome. |
| Q64079076 | Neuronal Redox-Imbalance in Rett Syndrome Affects Mitochondria as Well as Cytosol, and Is Accompanied by Intensified Mitochondrial O Consumption and ROS Release |
| Q50309402 | Oxidative stress in Rett syndrome: natural history, genotype, and variants. |
| Q43230803 | RNA sequencing and proteomics approaches reveal novel deficits in the cortex of Mecp2-deficient mice, a model for Rett syndrome |
| Q57052655 | Roles of mitochondria in neuronal development |
| Q91952627 | Tau overexpression impairs neuronal endocytosis by decreasing the GTPase dynamin 1 through the miR-132/MeCP2 pathway |
| Q38682455 | Temporal- and Location-Specific Alterations of the GABA Recycling System in Mecp2 KO Mouse Brains. |
| Q37598851 | The free radical scavenger Trolox dampens neuronal hyperexcitability, reinstates synaptic plasticity, and improves hypoxia tolerance in a mouse model of Rett syndrome. |
| Q34649133 | The role of genetics in the establishment and maintenance of the epigenome. |
| Q38023570 | The role of oxidative stress in Rett syndrome: an overview. |
| Q37281126 | Transcriptional regulation of the MET receptor tyrosine kinase gene by MeCP2 and sex-specific expression in autism and Rett syndrome |
| Q36042190 | Transcriptome analysis of human brain tissue identifies reduced expression of complement complex C1Q Genes in Rett syndrome. |
| Q96610148 | Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain |
| Q55654628 | Transcriptome level analysis in Rett syndrome using human samples from different tissues. |
| Q33814205 | Treatments for biomedical abnormalities associated with autism spectrum disorder. |
| Q59242526 | iPSC-derived neurons profiling reveals GABAergic circuit disruption and acetylated α-tubulin defect which improves after iHDAC6 treatment in Rett syndrome |
Search more.